ArticleNaunyn-Schmiedeberg's archives of pharmacology2026
Mechanistic insights into the mitigating role of dapagliflozin against radiation-triggered myocardial apoptosis: gating to AMPK-regulated autophagic machinery.
Article in Naunyn-Schmiedeberg's archives of pharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cardiovascular complications are a major, mortality-associated consequence of radiotherapy in breast and lung cancer patients. Dapagliflozin (DAPA), a sodium-glucose co-transporter 2 inhibitor, has recently exhibited significant cardioprotective properties in cancer patients. The present study evaluated the cardioprotective efficacy and the underlying molecular mechanisms of DAPA in a rat model of radiation-induced cardiotoxicity. Male Sprague-Dawley rats were randomized into four groups: the first served as control; the second received DAPA (1 mg/kg, p.o. for 28 days); the third and fourth were exposed to 15 Gy acute thoracic γ-irradiation, with the fourth group receiving DAPA for 28 days post-irradiation. The deleterious effect of radiation on cardiac tissue was evidenced by marked histopathological alterations, increased heart index, elevated serum CK-MB levels, alongside ECG changes, including bradycardia and tall T waves, all of which were significantly alleviated by DAPA treatment. DAPA exhibited significant cardiac antioxidant properties, as reflected by reduced MDA and increased reduced glutathione levels. Mechanistically, DAPA mediated AMPK phosphorylation and enhanced autophagy-related responses following irradiation, as evidenced by increased expression of autophagy proteins (LC3, Beclin-1), upregulating the transcription of autophagy-related genes (ATG5, ATG7, ATG12), and decreased SQSTM1/p62 accumulation. This autophagic activation was accompanied by a blockage of intrinsic cardiomyocyte apoptosis triggered by radiation, as shown by decreased transcription of p53 and Bax while increased Bcl2, resulted in a reduced Bax/Bcl2 ratio and suppressed cleaved caspase-3 expression. In conclusion, DAPA confers cardio-protection against radiation injury by improving oxidative status and modulating the balance between apoptosis and adaptive autophagy, accompanied by increased AMPK phosphorylation.
Indexed as
Identifiers
42803966What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.